Vivacta's ultrasensitive point-of-care immunochemistry system has achieved compliance with ISO 13485:2003
This clears the way for the company to partner with larger in-vitro diagnostic companies, which place major demands regarding compliance with global regulatory requirements.
Vivacta now has a documentation system that is readily accessible by all employees using computers in their working environment.
